 |
Duramycin |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1997-12-11 00:00:00 |
| Sponsor | Lantibio, Inc.;100 Europa Drive, Suite 421;Chapel Hill, North Carolina, 27517 |
Related Access Program
| |
Duramycin |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1997-12-11 00:00:00 |
| Sponsor | Lantibio, Inc.;100 Europa Drive, Suite 421;Chapel Hill, North Carolina, 27517 |